Coramaze Technologies develops the Tripair, a device repairing functional Tricuspid Regurgitation (fTR) in heart failure patients, to improve quality of life and reduce morbidity. The Tripair implant is anchored a-traumatically in the right atrium, enabling full retrievability and intra-procedural efficacy evaluation.
Location: Israel, Center District, Petah Tikva
Employees: 1-10
Total raised: $6.42M
Founded date: 2013
Investors 3
| Date | Name | Website |
| - | Elron Vent... | elronventu... |
| - | Elron Elec... | elron.com |
| - | High-Tech ... | htgf.de |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 02.09.2015 | Series A | $5.05M | - |
| 14.02.2014 | - | $1.37M | - |
Mentions in press and media 3
| Date | Title | Description | Source |
| 02.09.2015 | coramaze technologies Raises €4.5M in Series A Financing | coramaze technologies GmbH, a Munich, Germany-based medical device company, closed a €4.5m (US$ 5.15... | finsmes.co... |
| 02.09.2015 | Daily funding roundup - September 2, 2015 | Tanium landed $120M; NewsCred bagged $42M; Universal Avenue secured $5M ConnectedYard, an innovator... | vator.tv/n... |
| 14.02.2014 | coramaze technologies Raises €1M in Funding | coramaze technologies GmbH, an Essen, Germany-based medical device company focused on treatment of h... | finsmes.co... |